New
York-based Pfizer will begin testing its experimental COVID-19 vaccine in
children as young as 12.
The
drug maker says they will begin vaccinating older teens this week in Cincinnati
and then they will work to enroll 12 to 15-year-old children.
Researchers
leading the trial say parents are already expressing interest in having their
child participate
More
than half a million children in the United States have been diagnosed with
COVID-19.